학술논문

PIRTOBRUTINIB (LOXO‐305), A NEXT GENERATION HIGHLY SELECTIVE NON‐COVALENT BTK INHIBITOR IN PREVIOUSLY TREATED RICHTER TRANSFORMATION: RESULTS FROM THE PHASE 1/2 BRUIN STUDY.
Document Type
Article
Source
Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-2, 2p
Subject
Language
ISSN
02780232